At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 40 enrolled
Drug / intervention
Liquid powder +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Trial of Efficiency and Safety of Liquid Powder Containing Tapioca Starch Stimutex AS, Aloe Barbadensis, Rose Hip Oil and Allantoin Comparing With Topical 1% Hydrocortisone Cream for Treatment of Intertrigo
In Brief
A Phase 4 clinical trial evaluating Liquid powder and Hydrocortisone cream 1% for Intertrigo. Completed, enrolled 40 participants across 1 site.
Detailed Summary
A randomized controlled trial of efficiency and safety of liquid powder containing tapioca starch stimutex AS, aloe barbadensis, rose hip oil and allantoin comparing with topical 1% hydrocortisone cream for the treatment of intertrigo
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntertrigo
CountriesThailand
CollaboratorsHOE pharmaceuticals Sdn. Bhd.
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
First PostedMar 2020
Primary CompletionSep 2020
TodayJul 2026
First PostedMar 27, 2020
Enrollment StartOct 1, 2019
Primary CompletionSep 30, 2020
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.3 years ago
Interventions
Liquid powderdrug
apply the study drug 1 fingertip unit to cover intertrigo lesion twice a day for two weeks.
Hydrocortisone cream 1%drug
apply the study drug 1 fingertip unit to cover intertrigo lesion twice a day for two weeks.